LONDON(Dow Jones)–Chinese pharmaceutical sales company China Medical System Holdings Ltd. (CMSH.LN) Wednesday posted a 89% rise in full-year 2008 pretax profit and raised its final dividend.
For the year ended Dec.31， pretax profit increased to $19.5 million from $10.3 million in 2007.
Revenue rose to $72.6 million from $51.7 million.
China Medical said sales of its four drugs increased by as much as 50% year-on-year.
Sales of its Stulln Mono eye drops rose 47% while sales of its primary liver cancer drug GanFuLe increased 50%.
The company said it is recommending a final dividend of 10 cents a share， taking the total for the year to 15 cents – a 50% increase on last year‘s dividend.
(END) Dow Jones Newswires
May 13， 2009 03:08 ET(07:08 GMT)